Loading
NI-RADS scores the scans done after treatment for head and neck cancer, separately for the original tumour site and the neck lymph nodes, to say how likely it is that cancer has come back.
Neck masses after treatment for head and neck cancer are hard to interpret. The American College of Radiology's NI-RADS gives risk categories and management for surveillance imaging with CT, MRI or PET, scored separately for the primary site and the neck nodes. It applies to squamous cell carcinoma of the head and neck skin and the mouth, nasal cavity, nasopharynx, oropharynx, hypopharynx and larynx, and to non-squamous cancers of the salivary glands, sinuses, orbit and thyroid. The first white paper appeared in 2018; an MRI version, v2025, is the current release.
Showing the technology this term belongs to: CT (computed tomography).
Shares PI-RADS (Prostate Imaging Reporting and Data System), CT (computed tomography), MRI.
Shares Oropharyngeal cancer (tonsil and base of tongue), Oral cavity cancer (mouth and tongue), Head and neck squamous cell carcinoma.
Shares Oropharyngeal cancer (tonsil and base of tongue), Oral cavity cancer (mouth and tongue), Head and neck squamous cell carcinoma.
Shares Oropharyngeal cancer (tonsil and base of tongue), Oral cavity cancer (mouth and tongue), Head and neck squamous cell carcinoma.
Shares Laryngeal and hypopharyngeal cancer, Oropharyngeal cancer (tonsil and base of tongue), Head and neck squamous cell carcinoma.
Shares Oropharyngeal cancer (tonsil and base of tongue), Oral cavity cancer (mouth and tongue), Head and neck squamous cell carcinoma.
Shares PI-RADS (Prostate Imaging Reporting and Data System), CT (computed tomography).
Shares Oropharyngeal cancer (tonsil and base of tongue), Oral cavity cancer (mouth and tongue).
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/